Course of illness after the onset of chronic rejection in lung transplant recipients

American Journal of Critical Care

Volumn 17, Issue 3, 2008, Pages 246-253

  Song, Mi Kyung ^a   De Vito Dabbs, Annette ^b   Studer, Sean M ^c   Zangle, Sarah E ^d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC DISEASE; DEMOGRAPHY; FEMALE; GRAFT REJECTION; HEALTH SERVICE; HEALTH SURVEY; HUMAN; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; QUALITY OF LIFE; RETROSPECTIVE STUDY; SURVIVAL; TERMINAL CARE; TIME; UTILIZATION REVIEW;

CHRONIC DISEASE; DEMOGRAPHY; FEMALE; GRAFT REJECTION; HEALTH SERVICES; HEALTH STATUS INDICATORS; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TERMINAL CARE; TIME FACTORS;

EID: 47249139997     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2008.17.3.246     Document Type: Article

References (36)

1. Boehler A, Kesten S, Weder W, Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest. 1998;114(5): 1411-1426.
2. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21(3):297-310.
3. Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med. 1999;160(1):265-271.
4. Gross CR, Raghu G. The cost of lung transplantation and the quality of life post-transplant. Clin Chest Med. 1997; 18(2):391-403.
5. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant. 1998;17(12):1255-1263.
6. Lanuza DM, Lefaiver C, McCabe M, Farcas GA, Garrity E Jr. Prospective study of functional status and quality of life before and after lung transplantation. Chest. 2000;118(1): 115-122.
7. Verleden GM, Dupont LJ, Van Raemdonck DE. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J. 2005;25(2):221-224.
8. Hertz MI. Immunosuppression for prevention of bronchiolitis obliterans. Curr Opin Organ Transplant. 2000;5(4):402-406.
9. Yates B, Murphy DM, Forrest IA, et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2005;172(6):772-775.
10. Butler J, McCoin NS, Feurer ID, et al. Modeling the effects of functional performance and post-transplant comorbidities on health-related quality of life after heart transplantation. J Heart Lung Transplant. 2003;22(10):1149-1156.
11. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant. 2007;26(8):782-795.
12. DeVito Dabbs A, Hoffman LA, Iacono AT, et al. Pattern and predictors of early allograft rejection after lung transplantation. Am J Crit Care. 2003;12(6):497-507.
13. CT Transplant Group. Discharge Instructions: Patient Education After Cardiothoracic Transplantation. Pittsburgh, PA: University of Pittsburgh Medical Center; 2002.
14. United Network for Organ Sharing. Thoracic-lung data collection form. http://unos.org/SharedContentDocuments/Thoracic-Lung_Transplant_Recipient_Follow-Up.pdf. Published 2004. Accessed February 22, 2008.
15. Nathan SD, Ross DJ, Belman MJ, et al. Bronchiolitis obliterans in single-lung transplant recipients. Chest. 1995;107(4): 967-972.
16. Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg. 1995; 60(5):1341-1346.
17. Studer SM, Levy RD, McNeil K, Orens JB. Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J. 2004;24(4):674-685.
18. Van den Berg JW, Van Enckevort PJ, Ten-Vergert EM, Postma DS, Van der Bij W, Koëter GH. Bronchiolitis obliterans syndrome and additional costs of lung transplantation. Chest. 2000;118(6):1648-1652.
19. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. An economic evaluation of lung transplantation. J Thorac Cardiovasc Surg. 2002;123(3):411-420.
20. Ramsey SD, Patrick DL, Albert RK, Larson EB, Wood DE, Raghu G. The cost-effectiveness of lung transplantation: a pilot study. University of Washington Medical Center Lung Transplant Study Group. Chest. 1995;108(6):1594-1601.
21. Van Enckevort PJ, Koopmanschap MA, TenVergert EM, et al. Lifetime costs of lung transplantation: estimation of incremental costs. Health Econ. 1997;6(5):479-489.
22. Vasiliadis HM, Collet JP, Penrod JR, Ferraro P, Poirier C. A cost-effectiveness and cost-utility study of lung transplantation. J Heart Lung Transplant. 2005;24(9):1275-1283.
23. Vasiliadis HM, Collet JP, Poirier C. Health-related quality-of-life determinants in lung transplantation. J Heart Lung Transplant. 2006;25(2):226-233.
24. Brugière O, Pessione F, Thabut G, et al. Bronchiolitis obliterans syndrome after single-lung transplantation: impact of time to onset on functional pattern and survival. Chest. 2002;121(6):1883-1889.
25. Date H, Lynch JP, Sundaresan S, Patterson GA, Trulock EP. The impact of cytolytic therapy on bronchiolitis obliterans syndrome. J Heart Lung Transplant. 1998;17(9):869-875.
26. Jackson CH, Sharples LD, McNeil K, Stewart S, Wallwork J. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? J Heart Lung Transplant. 2002;21(6):658-666.
27. Iacono AT, Corcoran TE, Griffith BP, et al. Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans. Eur Respir J. 2004;23(3):384-390.
28. Chamberlain D, Maurer J, Chaparro C, Idolor L. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant. 1994;13(6):963-971.
29. Levine SM; Transplant/Immunology Network of the American College of Chest Physicians. A survey of clinical practice of lung transplantation in North America. Chest. 2004;125(4): 1224-1238.
30. Dabbs Ade V, Hoffman LA, Swigart V, et al. Striving for normalcy: symptoms and the threat of rejection after lung transplantation. Soc Sci Med. 2004;59(7):1473-1484.
31. Kotloff RM. Lung retransplantation: all for one or one for all? Chest. 2003;123(6):1781-1782.
32. Strueber M, Fischer S, Gottlieb J, et al. Long-term outcome after pulmonary retransplantation. J Thorac Cardiovasc Surg. 2006;132(2):407-412.
33. Hertz MI, Taylor DO, Trulock EP, et al. The Registry of the International Society for Heart and Lung Transplantation: nineteenth official report-2002. J Heart Lung Transplant. 2002;21(9):950-970.
34. US Organ Procurement and Transplantation Network. 2005 Annual report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: transplant data 1994-2003. http://www.optn.org/data/annualReport.asp. Accessed March 3, 2008.
35. Kurz JM. Experiences of well spouses after lung transplantation. J Adv Nurs. 2001;34(4):493-500.
36. Song MK, De Vito Dabbs AJ. Advance care planning after lung transplantation: a case of missed opportunities. Prog Transplant. 2006;16(3):222-225.